Tourmaline Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tourmaline Bio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Tourmaline Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $252K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $252K +$252K Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $290K -$537K -64.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $327K -$725K -68.9% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $362K -$127K -26% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $0 -$2.84M -100% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $827K -$2.21M -72.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.05M -$2.18M -67.4% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $489K -$2.91M -85.6% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $2.84M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.04M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $3.23M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $3.4M Jan 1, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.